Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas
Open accessThe DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Trousseau described spontaneous, recurrent superficial migratory thrombophlebitis associated with occult cancers, and this was later correlated with disseminated microangiopathy (platelet-rich clots in small blood vessels). Trousseau syndrome often occurs with mucinous adenocarcinomas, which secrete abnormally glycosylated mucins and mucin fragments into the bloodstream. Since carcinoma mucins can have binding sites for selectins, we hypothesized that selectin-mucin interactions might trigger this syndrome. When highly purified, tissue-factor free carcinoma mucin preparations were intravenously injected into mice, platelet-rich microthrombi were rapidly generated. This pathology was markedly diminished in P- or L-selectin–deficient mice. Heparin (an antithrombin-potentiating agent that can also block P- and L-selectin recognition of ligands) ameliorated this platelet aggregation, but had no additional effect in P- or L-selectin–deficient mice. Inhibition of endogenous thrombin by recombinant hirudin also did not block platelet aggregation. Mucins generated platelet aggregation in vitro in hirudinized whole blood, but not in platelet-rich leukocyte-free plasma nor in whole blood from L-selectin–deficient mice. Thus, Trousseau syndrome is likely triggered by interactions of circulating carcinoma mucins with leukocyte L-selectin and platelet P-selectin without requiring accompanying thrombin generation. These data may also explain why heparin ameliorates Trousseau syndrome, while vitamin K antagonists that merely depress thrombin production do not.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, extended segments of some mucins are even resistant to broad-spectrum proteases like proteinase K (511 -512).”
From Biological roles of glycans (2017) · cites this paper as [511]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevilacqua, M. P., Stengelin, S., Gimbrone, M. A., & Seed, B. (1989) · Science · doi:10.1126/science.2466335 · Cited by 2,005
Selectins and their ligands: Current concepts and controversies
Kansas, G. (1996) · Blood · doi:10.1182/blood.v88.9.3259.bloodjournal8893259 · Cited by 1,415
Varki, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7390 · Cited by 946
Self-citationMeyer, G., Marjanovic, Z., Valcke, J., Lorcerie, B., Gruel, Y., Solal-Celigny, P., Le Maignan, C., Extra, J. M., Cottu, P., & Farge, D. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1729 · Cited by 796
Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061615598 · Cited by 714 · cited 4×
“Immunodeficient RAG2–/– mice (129S6/SvEvTac-Rag2tm1; Taconic Farms, Germantown, New York, USA) and wild-type (C57bl/6J), P-selectin–deficient (P-sel–/–) (B6;129S-SelptmpHyn), and L-selectin–deficient (L-sel–/–) (B6;129S-SelltmlHyn) mouse strains were obtained from The Jackson Laboratory (Bar Harbor, Maine, USA) and cr…”
InfluentialSelf-citationSack, G. H., Levin, J., & Bell, W. R. (1977) · PubMed · Cited by 669
Molecular Cloning of the CA125 Ovarian Cancer Antigen
Yin, B. W. T., & Lloyd, K. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103554200 · Cited by 617
P-selectin induces the expression of tissue factor on monocytes.
Celi, A., Pellegrini, G., Lorenzet, R., De Blasi, A., Ready, N., Furie, B. C., & Furie, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8767 · Cited by 590
SACK, G. H., LEVIN, J., & BELL, W. R. (1977) · Medicine · doi:10.1097/00005792-197701000-00001 · Cited by 584
The Structure and Assembly of Secreted Mucins
Perez-Vilar, J., & Hill, R. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31751 · Cited by 531
Research works printed but not linked: 4
- Trousseau, A. 1868. Lectures on clinical medicine, delivered at the Hotel-Dieu, Paris. P.V. Bazire, editor and translator. The New Sydenham Society Publications. London, United Kingdom. 55 :281-332.
- Rhodes, J.M. 1999. Usefulness of novel tumour markers. Ann. Oncol. 4 (Suppl. 10):118-121. · doi:10.1023/a:1008369626649
- Beeley, J.G. 1985. Glycoprotein and proteoglycan techniques . Elsevier. New York, New York, USA. 73-78.
- Corriveau, D., and Fritsma, J. 1988. Hemostasis and thrombosis in the clinical laboratory . 1988. J.P. Lippincott Co. Philadelphia, Pennsylvania, USA. 443 pp.
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“fragments, or even from whole tissues (511, 512).”
BackgroundSelf-citationSialic acids in human health and disease
Varki, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.06.002 · Cited by 999
Self-citationProtein Glycosylation in Cancer
Stowell, S. R., Ju, T., & Cummings, R. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040438 · Cited by 873
Trousseau's syndrome: multiple definitions and multiple mechanisms
Varki, A. (2007) · Blood · doi:10.1182/blood-2006-10-053736 · Cited by 840
Self-citationCancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment
Abdol Razak, N., Jones, G., Bhandari, M., Berndt, M., & Metharom, P. (2018) · Cancers · doi:10.3390/cancers10100380 · Cited by 631
Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion
Rump, A., Morikawa, Y., Tanaka, M., Minami, S., Umesaki, N., Takeuchi, M., & Miyajima, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312372200 · Cited by 572
Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study
Khorana, A. A., Francis, C. W., Culakova, E., & Lyman, G. H. (2005) · Cancer · doi:10.1002/cncr.21496 · Cited by 565
Progression and metastasis of lung cancer
Popper, H. H. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9618-0 · Cited by 545
Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?
TESSELAAR, M. E. T., ROMIJN, F. P. H. T. M., VAN DER LINDEN, I. K., PRINS, F. A., BERTINA, R. M., & OSANTO, S. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02369.x · Cited by 548
Sialic acids in cancer biology and immunity
Pearce, O. M. T., & Läubli, H. (2016) · Glycobiology · doi:10.1093/glycob/cwv097 · Cited by 470
Selectins promote tumor metastasis
Läubli, H., & Borsig, L. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.04.005 · Cited by 461
Self-citationCancer Cell Adhesion and Metastasis: Selectins, Integrins, and the Inhibitory Potential of Heparins
Bendas, G., & Borsig, L. (2012) · International Journal of Cell Biology · doi:10.1155/2012/676731 · Cited by 458
Self-citationAy, C., Simanek, R., Vormittag, R., Dunkler, D., Alguel, G., Koder, S., Kornek, G., Marosi, C., Wagner, O., Zielinski, C., et al. (2008) · Blood · doi:10.1182/blood-2008-02-142422 · Cited by 422
Altered Tumor-Cell Glycosylation Promotes Metastasis
Häuselmann, I., & Borsig, L. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00028 · Cited by 382
Self-citationJurasz, P., Alonso‐Escolano, D., & Radomski, M. W. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706013 · Cited by 357
ROS1-dependent cancers — biology, diagnostics and therapeutics
Drilon, A., Jenkins, C., Iyer, S., Schoenfeld, A., Keddy, C., & Davare, M. A. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0408-9 · Cited by 294
Pancreatic cancer and thromboembolic disease
Khorana, A. A., & Fine, R. L. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01606-7 · Cited by 269
Blom, J. W., Osanto, S., & Rosendaal, F. R. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00928.x · Cited by 245
Glycomics: a pathway to a class of new and improved therapeutics
Shriver, Z., Raguram, S., & Sasisekharan, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1521 · Cited by 220
Stevenson, J. L., Choi, S. H., & Varki, A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1131 · Cited by 220
Self-citationRole of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences
Mezouar, S., Frère, C., Darbousset, R., Mege, D., Crescence, L., Dignat-George, F., Panicot-Dubois, L., & Dubois, C. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.01.006 · Cited by 218
Activation of blood coagulation in cancer: implications for tumour progression
Lima, L. G., & Monteiro, R. Q. (2013) · Bioscience Reports · doi:10.1042/bsr20130057 · Cited by 210
Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils
Zhang, M., Angata, T., Cho, J. Y., Miller, M., Broide, D. H., & Varki, A. (2007) · Blood · doi:10.1182/blood-2006-08-039255 · Cited by 204
Self-citationThe role of platelet activation in tumor metastasis
Borsig, L. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.8.1247 · Cited by 199
Self-citationSuzuki-Inoue, K. (2019) · Blood · doi:10.1182/blood.2019001388 · Cited by 189
Paraneoplastic thrombocytosis: the secrets of tumor self-promotion
Lin, R. J., Afshar-Kharghan, V., & Schafer, A. I. (2014) · Blood · doi:10.1182/blood-2014-03-562538 · Cited by 188
Mechanisms of Cancer-Induced Thrombosis in Cancer
Rickles, F. R. (2006) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000093551 · Cited by 176
Shao, B., Wahrenbrock, M. G., Yao, L., David, T., Coughlin, S. R., Xia, L., Varki, A., & McEver, R. P. (2011) · Blood · doi:10.1182/blood-2011-07-368514 · Cited by 166
Self-citationStarling, N., Rao, S., Cunningham, D., Iveson, T., Nicolson, M., Coxon, F., Middleton, G., Daniel, F., Oates, J., & Norman, A. R. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.4274 · Cited by 163
Campello, E., Ilich, A., Simioni, P., & Key, N. S. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0510-x · Cited by 161
Beyond Hemostasis: The Role of Platelets in Inflammation, Malignancy and Infection
McNicol, A., & Israels, S. J. (2008) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/187152908784533739 · Cited by 181
Disseminated intravascular coagulation and its immune mechanisms
Popescu, N. I., Lupu, C., & Lupu, F. (2021) · Blood · doi:10.1182/blood.2020007208 · Cited by 159
Pathophysiology of venous thrombosis
López, J. A., & Chen, J. (2009) · Thrombosis Research · doi:10.1016/s0049-3848(09)70140-9 · Cited by 142
Plantureux, L., Mège, D., Crescence, L., Dignat‐George, F., Dubois, C., & Panicot‐Dubois, L. (2018) · Cancers · doi:10.3390/cancers10110441 · Cited by 133
ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date
Gendarme, S., Bylicki, O., Chouaid, C., & Guisier, F. (2022) · Current Oncology · doi:10.3390/curroncol29020057 · Cited by 121
“leukocyte (L-) selectins could trigger platelet activation and the formation of microthrombi responsible for thromboembolic events [33].”
BackgroundInteraction between circulating cancer cells and platelets: clinical implication.
Lou, X., Sun, J., Gong, S.-Q., Yu, X., Gong, R., & Deng, H. (2015) · Chinese Journal of Cancer Research · doi:10.3978/j.issn.1000-9604.2015.04.10 · Cited by 158
Poor short-term outcome in patients with ischaemic stroke and active cancer
Kneihsl, M., Enzinger, C., Wünsch, G., Khalil, M., Culea, V., Urbanic-Purkart, T., Payer, F., Niederkorn, K., Fazekas, F., & Gattringer, T. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7954-6 · Cited by 115
Manfredi, A. A., Rovere, P. Q., D’Angelo, A., & Maugeri, N. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.008 · Cited by 123
Kappelmayer, J., & Nagy, B. (2017) · BioMed Research International · doi:10.1155/2017/6138145 · Cited by 134
The anti-cancer properties of heparin and its derivatives: a review and prospect
Ma, S., Mao, Z., Wu, Y., Liang, M., Wang, D., Chen, X., Chang, P.-A., Zhang, W., & Tang, J. (2020) · Cell Adhesion & Migration · doi:10.1080/19336918.2020.1767489 · Cited by 115
Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets
Chugh, S., Gnanapragassam, V. S., Jain, M., Rachagani, S., Ponnusamy, M. P., & Batra, S. K. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.08.003 · Cited by 120
Microvesicle‐associated tissue factor and Trousseau's syndrome
Conde, I. D., Bharwani, L. D., Dietzen, D. J., Pendurthi, U. R., Thiagarajan, P., & López, J. A. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02301.x · Cited by 101
Trousseau’s syndrome – what is the evidence?
Bergqvist, D., Wåhlander, K., Eriksson, H., Sternby, N. H., & Ögren, M. (2006) · Thrombosis and Haemostasis · doi:10.1160/th05-10-0694 · Cited by 99
Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk
Lipets, E. N., & Атауллаханов, Ф. И. (2015) · Thrombosis Journal · doi:10.1186/s12959-015-0038-0 · Cited by 105
Chiari, R., Ricciuti, B., Landi, L. M., Morelli, A. M., Delmonte, A., Spitaleri, G., Cortinovis, D. L., Lamberti, G., Facchinetti, F., Pilotto, S., et al. (2019) · Clinical Lung Cancer · doi:10.1016/j.cllc.2019.06.012 · Cited by 98
Mucins and TFF peptides of the tear film and lacrimal apparatus
Paulsen, F. P., & Berry, M. S. (2006) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2006.03.001 · Cited by 111
Tumoral pulmonary hypertension
Price, L., Seckl, M. J., Dorfmüller, P., & Wort, S. J. (2019) · European Respiratory Review · doi:10.1183/16000617.0065-2018 · Cited by 92
Glycan Antagonists and Inhibitors: A Fount for Drug Discovery
Brown, J. R., Crawford, B. E., & Esko, J. D. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701751611 · Cited by 94
Androgen deprivation and thromboembolic events in men with prostate cancer
Ehdaie, B., Atoria, C. L., Gupta, A., Feifer, A. H., Lowrance, W. T., Morris, M. J., Scardino, P. T., Eastham, J. A., & Elkin, E. B. (2011) · Cancer · doi:10.1002/cncr.26623 · Cited by 89
New Insights Into Cancer-Associated Thrombosis
Sousou, T., & Khorana, A. A. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.182196 · Cited by 82
Woei-A-Jin, F. J. S. H., Tesselaar, M. E. T., Rodriguez, P. G., Romijn, F. P. H. T. M., Bertina, R. M., & Osanto, S. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.170 · Cited by 81
Authimoolam, S. P., & Dziubla, T. D. (2016) · Polymers · doi:10.3390/polym8030071 · Cited by 88
Sasaki, M., Ikeda, H., & Nakanuma, Y. (2007) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2007.02.001 · Cited by 83
Pancreatic cancer and thromboembolic disease, 150 years after Trousseau.
Ansari, D., Ansari, D., Andersson, R., & Andrén‐Sandberg, Å. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2015.06.08 · Cited by 78
Pulmonary tumour thrombotic microangiopathy
Price, L., Wells, A. U., & Wort, S. J. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000297 · Cited by 76
Haemostasis impairment in patients with obstructive jaundice.
Papadopoulos, V. P., Filippou, D. K., Manolis, E. N., & Mimidis, K. (2007) · PubMed · Cited by 75
Selectins Facilitate Carcinoma Metastasis and Heparin Can Prevent Them
Borsig, L. (2004) · Physiology · doi:10.1152/nips.01450.2003 · Cited by 88
Self-citationThe Basic Principles of Pathophysiology of Venous Thrombosis
Schulman, S., Makatsariya, A. D., Khizroeva, J. K., Bitsadze, V. O., & Левановна, К. Д. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111447 · Cited by 78
Beatson, R., Graham, R. A., Freile, F. G., Cozzetto, D., Kannambath, S., Pfeifer, E., Woodman, N. L., Owen, J., Nuamah, R. A., Mandel, U., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01359-5 · Cited by 77
Circulating tissue factor-exposing microparticles
Lechner, D., & Weltermann, A. (2008) · Thrombosis Research · doi:10.1016/s0049-3848(08)70019-7 · Cited by 84
Platelets and Tumor Cells: A New Form of Border Control
Stanger, B. Z., & Kahn, M. L. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.009 · Cited by 76
Hypercoagulation and complement: Connected players in tumor development and metastases
Guglietta, S., & Rescigno, M. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.10.011 · Cited by 73
Mucin in cancer: a stealth cloak for cancer cells
Wi, D.-H., Cha, J., & Jung, Y. (2021) · BMB Reports · doi:10.5483/bmbrep.2021.54.7.064 · Cited by 68
Levi, M. M. (2014) · Thrombosis Research · doi:10.1016/s0049-3848(14)50012-6 · Cited by 61
Microparticles and thrombotic disease
Davizon, P. D., & López, J. A. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32832ea49c · Cited by 67
Fibrin and Platelet-Rich Composition in Retrieved Thrombi Hallmarks Stroke With Active Cancer
Fu, C.-H., Chen, C., Lin, Y., Lee, C., Tsai, L., Tang, S., Shun, C., & Jeng, J. (2020) · Stroke · doi:10.1161/strokeaha.120.032069 · Cited by 60
Paraneoplastic vasculitis and paraneoplastic vascular syndromes
Buggiani, G., Krysenka, A., Grazzini, M., Vašků, V., Hercogova, J. T., & Lotti, T. (2010) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2010.01367.x · Cited by 60
Activation of Clotting Factors in Cancer
Rickles, F. R., & Falanga, A. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-79962-9_3 · Cited by 59
Wahrenbrock, M. G., & Varki, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3851 · Cited by 58
“injection of carcinoma mucin fragments into mice triggers formation of extensive platelet- and leukocyte-rich microthrombi—a pathologic response that is thrombin independent but L-selectin and P-selectin dependent, and is heparin sensitive (37).”
InfluentialSelf-citationStark, K., Schubert, I., Joshi, U., Kilani, B., Hoseinpour, P., Thakur, M., Grünauer, P., Pfeiler, S., Schmidergall, T., Stockhausen, S., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310262 · Cited by 61
Sano, M., Takahashi, R., Ijichi, H., Ishigaki, K., Yamada, T., Miyabayashi, K., Kimura, G., Mizuno, S., Kato, H., Fujiwara, H., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-320608 · Cited by 61
A Functional Role for Hemostasis in Early Cancer Development
Boccaccio, C., & Comoglio, P. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2277 · Cited by 46
Palliative care for patients with advanced pancreatic and biliary cancers
Nakakura, E. K., & Warren, R. S. (2007) · Surgical Oncology · doi:10.1016/j.suronc.2007.08.003 · Cited by 45
Acute Limb Ischemia in Cancer Patients: Should We Surgically Intervene?
Tsang, J. S., Naughton, P. A., O’Donnell, J., Wang, T. T., Moneley, D. S., Kelly, C. J., & Leahy, A. L. (2011) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2011.06.002 · Cited by 40
Ito, D., Shiraishi, J., Nakamura, T., Maruyama, N., Iwamura, Y., Hashimoto, S., Kimura, M., Matsui, A., Yokoi, H., Arihara, M., et al. (2012) · Heart and Vessels · doi:10.1007/s00380-011-0222-5 · Cited by 39
Wenzel, J., Zeisig, R., & Fichtner, I. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9299-y · Cited by 45
Pathophysiology of Trousseau’s syndrome
Dicke, C., & Länger, F. P. (2014) · Hämostaseologie · doi:10.5482/hamo-14-08-0037 · Cited by 44
Glycobiology of platelet-endothelial cell interactions
Etulain, J., & Schattner, M. A. (2014) · Glycobiology · doi:10.1093/glycob/cwu056 · Cited by 39
Hong, C., Tsai, L., & Jeng, J. (2009) · Cerebrovascular Diseases · doi:10.1159/000235629 · Cited by 36
Tromboflebite superficial: epidemiologia, fisiopatologia, diagnóstico e tratamento
Sobreira, M. L., Yoshida, W. B., & Lastória, S. (2008) · Jornal Vascular Brasileiro · doi:10.1590/s1677-54492008000200007 · Cited by 35
Sudha, T., Phillips, P. G., Kanaan, C. M., Linhardt, R. J., Borsig, L., & Mousa, S. A. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9461-9 · Cited by 35
Self-citationTrappenburg, M. C., van Schilfgaarde, M., Bredewold, O. W., van Aalderen, M. C., Spronk, H. M. H., Cate, H. T., Leyte, A., & Terpstra, W. E. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2010.12.015 · Cited by 33
Imaging in the investigation of paraneoplastic syndromes
Rutherford, G.-C., Dineen, R. A., & O’Connor, A. (2007) · Clinical Radiology · doi:10.1016/j.crad.2007.06.005 · Cited by 33
Melanotransferrin induces human melanoma SK-Mel-28 cell invasion in vivo
Bertrand, Y., Demeule, M., Michaud‐Levesque, J., & Béliveau, R. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.034 · Cited by 32
The Auxiliary Role of Heparin in Bone Regeneration and its Application in Bone Substitute Materials
Wang, J., Xiao, L., Wang, W., Zhang, D., Ma, Y., Zhang, Y., & Wang, X. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.837172 · Cited by 61
Bazou, D., Santos-Martínez, M. J., Medina, C., & Radomski, M. W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01182.x · Cited by 34
Primary tumor and metastasis—sectioning the different steps of the metastatic cascade
Popper, H. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-175 · Cited by 32
Thromboembolism in Cancer Patients: Pathogenesis and Treatment
Adess, M. E., Eisner, R., Nand, S., Godwin, J. E., Messmore, H. L., & Wehrmacher, W. H. (2006) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029606291432 · Cited by 30
Medina, C., Harmon, S., Inkielewicz, I., Santos-Martínez, M. J., Jones, M., Cantwell, P., Bazou, D., Ledwidge, M. T., Radomski, M. W., & Gilmer, J. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01794.x · Cited by 30
Qureshi, W., Ali, Z., Amjad, W., Alirhayim, Z., Farooq, H., Qadir, S., Khalid, F., & Al-Mallah, M. H. (2016) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2016.00024 · Cited by 31
Suzuki‐Inoue, K. (2019) · Hematology · doi:10.1182/hematology.2019001388 · Cited by 29
Cerebral infarction associated with benign mucin-producing adenomyosis: report of two cases
Okazaki, K., Oka, F., Ishihara, H., & Suzuki, M. (2018) · BMC Neurology · doi:10.1186/s12883-018-1169-2 · Cited by 28
Wang, Z., Chen, G., Zhu, W., Jie-yong, B., Shen, X.-O., & Zhou, D. (2010) · PubMed · Cited by 28
Heparins Attenuate Cancer Metastasis: Are Selectins the Link?
Laubli, H. P., & Borsig, L. (2009) · Cancer Investigation · doi:10.1080/07357900802647136 · Cited by 27
Self-citationHigh risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1
Muñoz-Unceta, N., Zugazagoitia, J., Manzano, A., Jiménez-Aguilar, E., Olmedo, M. E., Cacho, J. D., Oliveira, J., Dómine, M., Ortega-Morán, L., Aguado, C., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.10.002 · Cited by 25
Carbohydrate clearance receptors in transfusion medicine
Sørensen, A. L. T., Clausen, H., & Wandall, H. H. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.07.008 · Cited by 29
Winters, J. P., & Garcia, D. A. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.05.004 · Cited by 25
Yang, C., Ma, R., Jiang, T., Cao, M., Zhao, L., Bi, Y., Kou, J., Shi, J., & Zou, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-4667-5 · Cited by 24
Tumor Genomic Profile Is Associated With Arterial Thromboembolism Risk in Patients With Solid Cancer
Feldman, S. A., Gupta, D., Navi, B. B., Ho, K.-W. G., Willeit, P., Devlin, S. M., Bolton, K. L., Arcila, M. E., & Mantha, S. H. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.01.009 · Cited by 25
Much More than Trousseau Syndrome. The Broad Spectrum of the Pancreatic Paraneoplastic Syndromes
Zalatnai, A., Perjési, E., & Galambos, E. (2017) · Pathology & Oncology Research · doi:10.1007/s12253-017-0206-6 · Cited by 24
Metadata
- Authors
- Wahrenbrock, M., Borsig, L., Le, D., Varki, N., & Varki, A.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Varki, Ajit
- Venue
- Journal of Clinical Investigation
- Published
- 2003-09-15
- Volume
- 112
- Issue
- 6
- Pages
- 853-862
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC193671
- OpenAlex
- W4249976229
- Cited by
- 317
- References
- 87
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 14 · 2023: 8 · 2022: 10 · 2021: 26 · 2020: 18 · 2019: 20 · 2018: 14 · 2017: 13 · 2016: 20 · 2015: 21 · 2014: 13 · 2013: 10 · 2012: 14
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service
- National Cancer Institute (R01 CA 38701, R01CA038701)
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- Trousseau syndrome, mucinous adenocarcinoma, P-selectin, L-selectin, platelet aggregation, microvascular thrombosis, heparin, hirudin, vitamin K antagonists, thrombophlebitis
- MeSH terms
- Animals, Antifibrinolytic Agents, Blood Platelets, Adenocarcinoma, Mucinous, Fibrinolytic Agents, Heparin, Humans, Lung, Mice, Inbred C57BL, Mucins, Neoplasm Transplantation, Paraneoplastic Syndromes, Syndrome, Thrombin, Thrombophlebitis, Thrombosis, Transplantation, Heterologous, Tumor Cells, Cultured, Vitamin K, Platelet Activation, Comorbidity, P-Selectin, L-Selectin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.